Skip to main content
. 2019 Mar 7;10:120. doi: 10.3389/fendo.2019.00120

Figure 2.

Figure 2

Schematic representation of the therapeutic approach to acromegalic patients with cardiovascular comorbidities and its reported effects. It is worth emphasizing that a prompt initiation of treatment allows a higher probabilitiy of cardiovascular control. In fact, regression of established alterations may be even feasible. A general management should be warranted, including smoking cessation, lifestyle modifications, and optimal pharmacotherapy for each of the potential problems encountered, including adequate control of glucose and lipid profiles. Besides, control of GH/IGF-I excess with the available acromegaly-directed treatment modalities further ameliorates cardiovascular comorbidities. ↓: decrease; ↑: increase.